Conflict of interest Type 1 diabetes >20 years - age 23 Pens: -Aspartate insulin (Novorapid): GM human; 3 X 12 units -Glargine (Lantus): GM human: 36.

Slides:



Advertisements
Similar presentations
Presentation title Emergency Care Part 3: Surgery in Children with Diabetes.
Advertisements

Management of Inpatient Hyperglycemia in Special Populations
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Washington State Hospital Association Partnership for Patients Reducing Surgical Site Infections: Glucose Control Clinical Presentation July 10, 2012.
Glycemic Control: Hospitalized Patients Review of Guidelines Lukasz Materek Endocrine Rounds September 2011.
Hyperglycaemia Diabetes Outreach (August 2011). 2 Hyperglycaemia Learning objectives >Can state what hyperglycaemia is >Is aware of the short term and.
Diabetes and dementia Jackie watts Clinical Advisor Diabetes UK.
MMI Task Force on Diabetes House Staff Curriculum.
Stepwise approach to inpatient diabetes management Erin Keely.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Paediatric Diabetes Nurses October 2013 Diabetes Update.
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Correction Insulin for Inpatient Hyperglycemia Estelle Lin June 2012.
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
Insulin therapy.
Insulin Prescribing.
Hba1c for diagnosis Dr Karen Adamson. β-chain α-chain Glucose bound to N-terminal valine of β-chain.
Perioperative Diabetes Management Dr. Ken Locke March 2007.
Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,
Periop. Cases on Endocrine Disorders Thomas Maniatis Dec. 16, 2010.
INSULIN THERAPY IN TYPE 1 DIABETES
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Diabetes Management in the Hospital: Case Studies Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.
Management of Adults with Diabetes undergoing Surgery and Elective Procedures UHL Guideline – April 2013 The aim of the guideline is to improve standards.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.

Update on Diabetes Services 41 st Annual General Practitioner Study Day 28 th January 2012 Dr. Eoin O’Sullivan Consultant Endocrinologist Bon Secours Cork.
ACUTE COMPLICATIONS. 18 years old diabetic patient was found to be in coma What questions need to be asked ? Differentiating hypo from hyperglycemia ?
MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.
Inpatient Glycemic Management
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Adult Medical-Surgical Nursing Endocrine Module: Acute Complications of Diabetes Mellitus.
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Insulin Conundrums Veronica Green *p < **p = Epidemiological extrapolation showing benefit of a 1% reduction in mean HbA 1c with a mean.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Prevention of SSI- Applying the Glucose Control Component Sharing the HHS Experience Dr. Richard McLean, MD, FRCP(C) Emily Christoffersen RN, BScN Rhonda.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
diabetes Prior classification of diabetes 1.Diabetes mellitus a. type1-insullin-dependent diabetes mellitus b. type2-noninsullin- dependent diabetes mellitus.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Achieving Glycemic Control in the Hospital Setting Part 1 of 3
New Insulin Formulations Guillermo Umpierrez, MD, FACP, FACE Professor of Medicine Emory University School of Medicine Part 1.
Insulin Initiation In Primary Care Dr Arla Ogilvie Endocrinologist Watford General Hospital West Herts Hospitals NHS Trust.
21 st October 2011 Perioperative Care of the Person with Diabetes Alison Gebuehr CNC Diabetes JHH Credentialled Diabetes Educator Adapted from presentation.
Welcome to Class You made a great choice! To decide, to be a t the level of choice, is to take responsibility for your life and to be in control of your.
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
Insulin Elixir of life Dr. Sergio Diez Alvarez Staff Specialist Physician.
Diabetes Mellitus: Prevention & Treatment Medical surgical in nursing /02/01.
Achieving Glycemic Control in the Hospital Setting
Diabetes, Surgery and GKI’s Maureen Wallymahmed Nurse Consultant - Diabetes.
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Special Situations In The Management Of In-Patient Hyperglycemia
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
DEVELOPED IN PART BY THE COMMUNITY WELLNESS TEAM Diabetes GETTING STARTED.
TYPE 1 DIABETES UPDATE Colorado Association for School-Based Health Care G. Todd Alonso, MD May 6, 2016.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
HbA1c before Ramadan (%)
Management of diabetes mellitus in hospitalized patients
Diabetic hypoglycemia from prevention to management.
Dr. Richard McLean, MD, FRCP(C) Emily Christoffersen RN, BScN
Managing Hypoglycemia & Hyperglycemia
Hba1c for diagnosis Dr Karen Adamson.
Insulin Delivery Systems Atlanta Diabetes Associates
Presentation transcript:

Conflict of interest Type 1 diabetes >20 years - age 23 Pens: -Aspartate insulin (Novorapid): GM human; 3 X 12 units -Glargine (Lantus): GM human: 36 units nocte -BSL – Glucometer 5 seconds: digital + log Gerich, Am J Med, 2002

Topics: New role for HbA1c New insulins Perioperative glucose control

Frequency perioperative diabetes REASON study 4,150 older inpatients 23 hospitals ANZ 22% diabetes, 30-day mortality 5% (OR 1.0) -27% IHD (20% all) -26% CRI (16% all) Story et al, Anaesthesia, 2010

Diabetes diagnosis Random BSL >11mmol/L Fasting BSL ≥ 7 mmol/L OGTT 2hr BSL >11mmol/L –Diabetes likely –Diabetes unlikely –Impaired glucose tolerance, >5.5 mmol/L Diabetes Australia + RACGP, Diabetes Management, 2009

Diabetes “severity” Using haemoglobin A1C: HbA 1c “A1C” Hb + glucose irreversibly attached to beta chain A1C - 3 months; <30 days 50%, 60 to 120 days 25% A1CMean BSL 6% 7.5 mmol/L 7% 9.5 mmol/L 8% 11.5 mmol/L 9%13.5 mmol/L 10%15.5 mmol/L Burtis et al, Tietz Textbook Clinical Chemistry, 2006

Not acute Type 1 RBG > 11 mmol/L diagnostic Diabetes Care, 2009 Endorsed by Diabetes Society of Australia

A1C ≥6.5% DM, 6.0% to 6.4% Intolerance Diabetes Care, 2009

Medical Journal of Australia 2011 Flinders % (262/2360) undiagnosed 666 surgical patients 52 (8%) known diabetes 54 (8%) unknown diabetes

Surgery, A 1C and infection 490 diabetic patients, non-cardiac VA Conneticut Median age 72, median A1C 7.3% A1C < 7.0%, n= 197, infection 12% A1C ≥ 7.0%, n= 293, infection 20% Adjusted OR A1C ≥ 7.0%, infection OR 2.1 (1.2 to 3.7) Dronge et al, Arch Surg, 2006

Ann Thorac Surg, 2009

New Insulins Killen et al, Anaesth Intensive Care, 2010

Insulin Pumps Basal rapid acting infusion + boluses Killen et al, Anaesth Intensive Care, 2010

Hypoglycemia Variation between and within US mg/dl = mmol/L X 18 approx mg/dl = 11.1 mmol/L (approx 10 mmol/L) Reference Range: 4 mmol/L to 6 mmol/L 3 mmol/L – sympathetic – sweating, hunger 2.5 mmol/L – altered CNS: confusion, diplopia Eventually coma, death Service, NEJM, 1995

Perioperative diabetes Limited evidence Glister + Vigersky, Endocrinol Metab Clin N Am, 2003 Ask patient: “What and when” - sugar and insulin Three parts: -Basal: glargine – avoids ketosis (cf GIK) -Nutritional – rapid (W/H) -Corrective –rapid s/c or IV regular Assundi + Calles-Escandon, J Hosp Med, 2007 Killen et al, Anaesth Intensive Care, 2010

Dumb things with insulin Forget to take it Take twice –short –long Take wrong one Take too much Eat too much for usual dose Eat too little for usual dose Unusual and/or stressful situations

Insulin pumps Beware: Technology + no underlying long acting Options: IV regular infusion at basal rate (day surgery) Continue with pump if confident Convert to s/c rapid + glargine Assundi + Calles-Escandon, J Hosp Med, 2007 Killen et al, Anaesth Intensive Care, 2010

Perioperative diabetes Measure the blood sugar

What BSL? Aim: 8 mmol/ L (5 to 10 mmol/L) NICE-SUGAR: 6000 ICU patients 4.5 to 6.0 mmol/L (tight) vs <10 mmol/L (usual) 90 day mortality, Tight control surgical OR: 1.31 Hypos 6.8% vs 0.5% NICE-SUGAR Investigators NEJM, 2009

Hypo…how much dextrose? Mild to mod: 3 to 5 mmol/L; severe < 3 mmol/L Don’t over treat: target 8 mmol/L (5 to 10 mmol/L) –Dextrose 5% = 5 g/100ml –Dextrose 50% = 50 g/100 ml = 5g/10 ml IV push BSL 3-5 Dose = 0.1 g/kg 2ml/kg 5% dextrose BSL < 3 Dose = 0.15 g/kg 3ml/kg 5% dextrose Can’t remember = 150 ml 5% Dextrose (7.5g) = 15 ml 50% Assundi + Calles-Escandon, J Hosp Med, 2007

You can drink D5W …but the taste isn’t great

Why is the patient hypo? Poor management: eg delay Mistake in insulin or intake? Is the problem fixed? –beware duration too much long-acting Beware insulin infusions

Most likely…hyperglycemia My glucometer on Christmas day…

Most likely…hyperglycemia BSL > 10 mmol/L Hours: unpleasant hyperosmolar, dehydrated Don’t over treat; target 8 mmol/L (5 to 10 mmol/L) 80/total daily insulin = 1 unit effect mmol/L BSL Me: 72 units / day 80/72 = 1.1 mmol/L for 1 unit Adult rule of thumb: BSL - 8 = IV regular insulin OR S/C rapid Glister + Vigersky, Endocrinol Metab Clin N Am, 2003

Then 15 minutes later… Measure the blood sugar

Postop Physicians Three parts (alternative to insulin infusion) 0.5 units / kg / day (conservative start) -Basal: glargine 0.25 units / kg / day -Nutritional –rapid s/c 0.25 units / kg / day -Corrective – rapid s/c RABBIT 2, Diabetes Care 2011 Assundi + Calles-Escandon, J Hosp Med, 2007

Higher A1C less tolerant of lower glucose Egi et al, Crit Care Med, 2010

Acclimatization

Concluding thoughts… Balance of probabilities: A1C in all coronary + vascular patients ?A1C in others eg 70+ No DM + A1C >6% - med review – risks A1C >8% +/- DM - med review Research: A1C in ANZ populations: complications :RCT usual care vs A1C < 7.0 preop Measure the blood sugar

Concluding thoughts… No evidence for very tight control in OR Aim: 8 mmol/L (Range: 5 to 10 mmol/L) Give basal W/H rapid Don’t overreact Use IV regular or s/c rapid to correct Beware pumps Antiemetics D5W is our friend Endocrine involvement for O/N stay Measure the blood sugar Ahmed et al, Anaesth Analg, 2005

You forgot to measure the blood sugar?!? Thanks